Kathryn Hayashi

Kathryn Hayashi serves as the CEO of TRIUMF Innovations Inc. since February 2017, and co-leads the Canadian Medical Isotope Ecosystem, which aims to enhance the medical isotope sector in Canada. Additionally, Kathryn holds positions as an Executive Committee Member of the Canadian Nuclear Isotope Council and a Board Member at Michael Smith Health Research BC, where Kathryn chairs the Audit and Finance Committee. In their diverse experience, Kathryn has been a Board Member at Discovery Parks and C3i, and previously served as a Director at Sitka Biopharma and Zucara Therapeutics Inc. Kathryn's early career includes roles as CFO at the Centre for Drug Research & Development and VP Finance at Chromos. Kathryn earned a Bachelor of Commerce degree in Finance and Accounting from The University of British Columbia.